$GBSN (Great Basin Scientific, Inc.)

$GBSN {{ '2016-09-15T10:08:39+0000' | timeago}} • Announcement

Diagnostics company $GBSN said a 1-for-80 reverse split of its stock will be effective and the stock will open for trading on NASDAQ on Sept. 16. At the effective time of stock split, every 80 shares of issued and outstanding common stock will be consolidated into one newly-issued and outstanding share of common stock.

$CELG {{ '2018-01-22T13:26:32+0000' | timeago}} • Announcement

Last week's rumor becomes reality. $CELG to acquire its strategic partner $JUNO for $9Bil. Juno Therapeutics, which had already skyrocketed nearly 50% in the last week, has increased more than 25% today in pre-market from Jan. 19th closing price of $67.81. Celgene expects that this deal will help it to boost the revenue generation beyond 2020.

$CFG {{ '2018-01-19T17:56:28+0000' | timeago}} • Announcement

Citizens Financial fourth quarter profits more than doubled to $666MM, which included a tax benefit of $317MM. Net interest income and non-interest income improved 9.5% and 7.1% respectively, while non-interest expenses also were up 6%. Net interest margin improved 18 bps to 3.08%. $CFG's board declared a quarterly cash dividend of $0.22 per share.

$CFG {{ '2018-01-19T17:04:38+0000' | timeago}} • Infographic

$CFG Citizens Financial Group Earnings AlphaGraphic: Q4 2017 Highlights

$SYF {{ '2018-01-19T13:56:05+0000' | timeago}} • Announcement

Synchrony's profits slipped 33% to $385MM primarily due to one-time tax expenses ($160MM). Net interest income rose 8% to $3.9Bil, while deposits increased 9% vs. 4Q16. However, loan loss provisions were up 25.8% to $1.4Bil due to credit normalization. $SYF expects the acquisition of PayPal’s US consumer credit receivables assets to close in 3Q18.

$SYF {{ '2018-01-19T13:19:09+0000' | timeago}} • Infographic

$SYF Synchrony Financial Earnings AlphaGraphic: Q4 2017 Highlights

$HOLX {{ '2018-01-16T13:05:50+0000' | timeago}} • Announcement

$HOLX said its CE-marked Aptima HIV-1 Quant Dx assay has been awarded World Health Organization (WHO) prequalification for in vitro diagnostic. The Aptima HIV-1 Quant Dx assay is the first HIV-1 viral load assay with a dual claim for both diagnosis and treatment monitoring.

$ILMN {{ '2018-01-16T12:42:12+0000' | timeago}} • Announcement

Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, appointed Dawn Barry as president. Previously, Barry served as the VP of Applied Genomics at $ILMN.

$HOLX {{ '2018-01-11T21:23:15+0000' | timeago}} • Announcement

Medical technology company $HOLX has elected Namal Nawana to its board of directors, effective immediately. Nawana was formerly the CEO of Alere, Inc. Prior to that, he served Johnson & Johnson in various leadership roles, including Worldwide President of DePuy Synthes Spine.

$TMO {{ '2018-01-09T12:43:22+0000' | timeago}} • Announcement

$TMO, a leading medical technology company, has signed an agreement with life sciences firm $ILMN, under which Thermo Fisher will provide Illumina with Ion AmpliSeq technology. The tie-up will help Illumina effectively sell Ion AmpliSeq technology to researchers engaged in scientific studies on its next-generation sequencing (NGS) platforms.

$HOLX {{ '2018-01-08T13:10:32+0000' | timeago}} • Announcement

Medical technology company $HOLX said it is currently looking for net revenues of about $791MM for the first quarter of 2018, higher than $775MM-$790MM the company had estimated earlier. The latest guidance represents an 8% YoY growth, reflecting the effect of divestiture of Hologic’s blood screening business and acquisition of Cynosure.

$HOLX {{ '2018-01-03T13:10:03+0000' | timeago}} • Announcement

$HOLX said the MyoSure MANUAL device, which was designed to simplify tissue removal procedures regardless of setting, has received CE mark in Europe. The MyoSure MANUAL device joins the MyoSure suite of gynecologic surgical products that offer simple and effective solutions to resect and remove tissue.

$JNJ {{ '2018-01-02T19:20:09+0000' | timeago}} • Announcement

$JNJ declared a cash dividend for 1Q18 of $0.84 per share on the company's common stock. The dividend is payable on March 13, 2018 to shareholders as on Feb 27, 2018.

$BDX {{ '2017-12-29T16:54:30+0000' | timeago}} • Announcement

$BDX acquired $BCR. Beginning with 2Q18, $BDX will report a new Interventional segment structure, which will include a majority of Bard offerings, with the remainder being reported under the Medical segment.

$BDX {{ '2017-12-29T16:54:14+0000' | timeago}} • Announcement

$BDX has acquired $BCR. $BDX does not expect the acquisition to have a material impact on its financial results in 1Q18. $BDX expects the transaction to generate low-single digit accretion to adjusted EPS in FY18, and high-single digit accretion in FY19.

$BDX {{ '2017-12-29T16:53:59+0000' | timeago}} • Announcement

$BDX completed the acquisition of $BCR. Under the terms of the transaction, Bard became a wholly owned subsidiary of $BDX, and each outstanding share of Bard common stock was converted to the right to receive $222.93 in cash without interest, and 0.5077 of a share of $BDX common stock. Bard shares will cease trading and be delisted from the NYSE.

$BDX {{ '2017-12-28T12:35:48+0000' | timeago}} • Announcement

$BDX gets clearance from the Ministry of Commerce of the People's Republic of China (MOFCOM) to acquire $BCR. BD and Bard expect the proposed acquisition to close on Dec. 29. Separately, BD's proposed divestiture of its soft tissue core needle biopsy product line to Merit Medical is conditioned on MOFCOM approval of Merit as the purchaser.

$JNJ {{ '2017-12-21T18:10:50+0000' | timeago}} • Announcement

Janssen Biotech, a $JNJ company, said the FDA has granted Priority Review designation for the New Drug Application (NDA) for apalutamide as treatment for non-metastatic castration-resistant prostate cancer (CRPC). This is the first agent submitted for approval to treat earlier stage castration-resistant prostate cancer at high risk for metastasis.

$ALL {{ '2017-12-21T16:52:14+0000' | timeago}} • Announcement

$ALL elected Margaret Keane, president and CEO of $SYF, to its BoD, effective Jan. 1. As of that date, the Allstate board will stand at 12 directors.

$RHT {{ '2017-12-20T14:24:30+0000' | timeago}} • Announcement

Open source software provider $RHT, which recently announced partnerships with $BABA and SoftBank, saw a surge in its 3Q18 profit, driven by higher subscriptions and higher revenue. Profit surged 49% to $101.3MM or $0.54 per share, up from $68MM or $0.37 a year earlier. Revenue rose 22% to $748MM. On an adjusted basis, $RHT earned $0.73 per share.

$ABT {{ '2017-12-15T16:46:17+0000' | timeago}} • Announcement

$ABT increased the company's quarterly common dividend to $0.28 per share from $0.265 per share.  The cash dividend is payable Feb. 15, 2018, to shareholders of record at the close of business on Jan. 12, 2018.

Recent Transcripts

CFG (Citizens Financial Group, Inc.)
Friday, January 19 2018 - 2:00pm
SYF (Synchrony Financial)
Friday, January 19 2018 - 1:30pm
HOLX (Hologic Inc.)
Wednesday, November 8 2017 - 9:30pm
APPS (Digital Turbine, Inc.)
Tuesday, November 7 2017 - 9:30pm
QGEN (Qiagen NV)
Tuesday, November 7 2017 - 2:00pm
GNMK (GenMark Diagnostics, Inc.)
Thursday, November 2 2017 - 8:30pm
AXDX (Accelerate Diagnostics, Inc.)
Thursday, November 2 2017 - 8:15pm
BDX (Becton, Dickinson and Company)
Thursday, November 2 2017 - 12:00pm
BABA (Alibaba Group Holding Limited)
Thursday, November 2 2017 - 11:30am
QDEL (Quidel Corp.)
Wednesday, November 1 2017 - 9:00pm
JUNO (Juno Therapeutics Inc.)
Wednesday, November 1 2017 - 8:30pm
LMNX (Luminex Corporation)
Monday, October 30 2017 - 8:30pm
ILMN (Illumina Inc.)
Tuesday, October 24 2017 - 9:00pm
CFG (Citizens Financial Group, Inc.)
Friday, October 20 2017 - 1:00pm
SYF (Synchrony Financial)
Friday, October 20 2017 - 12:30pm
ABT (Abbott Laboratories)
Wednesday, October 18 2017 - 1:00pm
JNJ (Johnson & Johnson)
Tuesday, October 17 2017 - 12:30pm
BABA (Alibaba Group Holding Limited)
Thursday, August 17 2017 - 11:30am
APPS (Digital Turbine, Inc.)
Monday, August 7 2017 - 8:30pm
LMNX (Luminex Corporation)
Monday, August 7 2017 - 8:30pm

AlphaGraphics you may like